Effects of misoprostol on lipoprotein (a) levels of ovariectomized rats
dc.contributor.author | Sonmez, AS | |
dc.contributor.author | Birincioglu, M | |
dc.contributor.author | Turkoz, Y | |
dc.contributor.author | Adam, B | |
dc.contributor.author | Lurie, D | |
dc.contributor.author | Chuong, CJ | |
dc.date.accessioned | 2024-08-04T20:12:03Z | |
dc.date.available | 2024-08-04T20:12:03Z | |
dc.date.issued | 1999 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: To determine the effects of misoprostol on plasma lipoprotein (a) concentrations of ovariectomized rats. Design: Controlled prospective study. Setting: Animal research laboratory. Animal(s): Four-month-old female Sprague-Dawley rats. Intervention(s): Blood samples were obtained before and 60 days after ovariectomy, and the rats were divided into three groups. Group I (five rats) was treated with vehicle (water); groups II and III (nine and eight rats, respectively) were treated with oral misoprostol at 100 and 200 mu g/kg/d, respectively, for 60 days, after which blood was drawn again. Main Outcome Measure(s): Serum lipoprotein (a) levels. Result(s): The median lipoprotein (a) level before ovariectomy was 10.8 mg/dL (range, 10.6-46.5 mg/dL). Sixty days after ovariectomy, the level increased significantly to 15.9 mg/dL (range, 10.6-36.9 mg/dL). After treatment, there was no change in lipoprotein (a) levels in the vehicle-treated group (range, 16.3-21.1 mg/dL); however, the lipoprotein (a) levels decreased significantly in the group treated with 100 mu g/kg/d of misoprostol, from 15.4 mg/dL to 10.8 mg/dL, and in the group treated with 200 mu g/kg/d of misoprostol, from 17.1 mg/dL to 10.6 mg/dL. Conclusion(s): Misoprostol caused a significant decrease in lipoprotein (a) levels. (Fertil Steril(R) 1999;72: 518-21. (C) 1999 by American Society for Reproductive Medicine.) 518. | en_US |
dc.identifier.doi | 10.1016/S0015-0282(99)00286-1 | |
dc.identifier.endpage | 521 | en_US |
dc.identifier.issn | 0015-0282 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 10519627 | en_US |
dc.identifier.scopus | 2-s2.0-0033200088 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 518 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0015-0282(99)00286-1 | |
dc.identifier.uri | https://hdl.handle.net/11616/93184 | |
dc.identifier.volume | 72 | en_US |
dc.identifier.wos | WOS:000082365600023 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Fertility and Sterility | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | misoprostol | en_US |
dc.subject | lipoprotein (a) | en_US |
dc.subject | ovariectomized rat | en_US |
dc.title | Effects of misoprostol on lipoprotein (a) levels of ovariectomized rats | en_US |
dc.type | Article | en_US |